A Single-dose, Randomized, Open-label, Crossover Bioequivalence Study of Generic Azilsartan Medoxomil 80 mg Tablets and Reference Product in Healthy Thai Participants under Fasting Conditions
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Lacosamide Film Coated Tablets 100 mg relative to VIMPAT Film Coated Tablets 100 mg in Thai healthy participants under fasting condition
An open label, randomized, two-treatment, two-sequence, two-period, crossover, single-dose comparative oral bioavailability study of MYOTRAM-P 37.5/325 mg (Test) and Ultracet (Reference) in 32 healthy, adult, human participants under fasting conditions
100 项与 Bio-Innova Co. Ltd. 相关的临床结果
0 项与 Bio-Innova Co. Ltd. 相关的专利（医药）
100 项与 Bio-Innova Co. Ltd. 相关的药物交易
100 项与 Bio-Innova Co. Ltd. 相关的转化医学
